A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study

ACQ de Vries; Bing Thio; WJA de Kort; BC Opmeer; HM van der Stok; EMGJ de Jong; B Horvath; Jan van Busschbach; Tamar Nijsten; PI Spuls

doi:10.1111/bjd.14867

A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study

ACQ de Vries
, Bing Thio
, WJA de Kort
, BC Opmeer
, HM van der Stok
, EMGJ de Jong
, B Horvath
, Jan van Busschbach
, Tamar Nijsten
, PI Spuls

Research output: Contribution to journal › Article › Academic › peer-review

47 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	624-633
Number of pages	10
Journal	British Journal of Dermatology
Volume	176
Issue number	3
DOIs	https://doi.org/10.1111/bjd.14867
Publication status	Published - 2017

Research programs

EMC OR-01

Access to Document

10.1111/bjd.14867

http://hdl.handle.net/1765/97797

Cite this

de Vries, ACQ., Thio, B., de Kort, WJA., Opmeer, BC., van der Stok, HM., de Jong, EMGJ., Horvath, B., van Busschbach, J., Nijsten, T., & Spuls, PI. (2017). A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study. British Journal of Dermatology, 176(3), 624-633. https://doi.org/10.1111/bjd.14867

@article{4a08c8eed7da435c9638f77dd3ba6de4,

title = "A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study",

author = "\{de Vries\}, ACQ and Bing Thio and \{de Kort\}, WJA and BC Opmeer and \{van der Stok\}, HM and \{de Jong\}, EMGJ and B Horvath and \{van Busschbach\}, Jan and Tamar Nijsten and PI Spuls",

year = "2017",

doi = "10.1111/bjd.14867",

language = "Undefined/Unknown",

volume = "176",

pages = "624--633",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Oxford University Press",

number = "3",

}

de Vries, ACQ, Thio, B, de Kort, WJA, Opmeer, BC, van der Stok, HM, de Jong, EMGJ, Horvath, B, van Busschbach, J , Nijsten, T & Spuls, PI 2017, 'A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study', British Journal of Dermatology, vol. 176, no. 3, pp. 624-633. https://doi.org/10.1111/bjd.14867

A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study. / de Vries, ACQ; Thio, Bing; de Kort, WJA et al.
In: British Journal of Dermatology, Vol. 176, No. 3, 2017, p. 624-633.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study

AU - de Vries, ACQ

AU - Thio, Bing

AU - de Kort, WJA

AU - Opmeer, BC

AU - van der Stok, HM

AU - de Jong, EMGJ

AU - Horvath, B

AU - van Busschbach, Jan

AU - Nijsten, Tamar

AU - Spuls, PI

PY - 2017

Y1 - 2017

U2 - 10.1111/bjd.14867

DO - 10.1111/bjd.14867

M3 - Article

C2 - 27416891

SN - 0007-0963

VL - 176

SP - 624

EP - 633

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 3

ER -

de Vries ACQ, Thio B, de Kort WJA, Opmeer BC, van der Stok HM, de Jong EMGJ et al. A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study. British Journal of Dermatology. 2017;176(3):624-633. doi: 10.1111/bjd.14867